Zobrazeno 1 - 10
of 529
pro vyhledávání: '"Ronald, Levy"'
Publikováno v:
Viruses, Vol 16, Iss 1, p 76 (2024)
The first- and second-generation clinically used HIV-1 integrase (IN) strand transfer inhibitors (INSTIs) are key components of antiretroviral therapy (ART), which work by blocking the integration step in the HIV-1 replication cycle that is catalyzed
Externí odkaz:
https://doaj.org/article/4cf5d25e025f486ba1df67ffec6b8500
Autor:
Ole A. W. Haabeth, Julian J. K. Lohmeyer, Adrienne Sallets, Timothy R. Blake, Idit Sagiv-Barfi, Debra K. Czerwinski, Blaine McCarthy, Abigail E. Powell, Paul A. Wender, Robert M. Waymouth, Ronald Levy
Publikováno v:
ACS Central Science, Vol 7, Iss 7, Pp 1191-1204 (2021)
Externí odkaz:
https://doaj.org/article/86bb0ef635a54b0b80cf96a5c31c42a3
Autor:
Idit Sagiv-Barfi, Ronald Levy, Caitlyn Miller Candidate, Patrick Neuhoefer, Debra Czerwinski, Steven Artandi, Carolyn Bertozzi, Jennifer Cochran
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/d261fc7abf534abcac455f3d8c5824a9
Autor:
Ronald Levy, Joshua Brody, David L Porter, Sattva S Neelapu, Koen Van Besien, Michael Werner, Michael R Bishop, Mitchell S Cairo, Sherry Adkins, Stephen M Ansell, Jonathan W Friedberg, Justin P Kline
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
The recent development and clinical implementation of novel immunotherapies for the treatment of Hodgkin and non-Hodgkin lymphoma have improved patient outcomes across subgroups. The rapid introduction of immunotherapeutic agents into the clinic, how
Externí odkaz:
https://doaj.org/article/2fb77ce0a5a54f93aaa50a040c2bdee0
Autor:
Michael Mentz, William Keay, Carolin Dorothea Strobl, Martina Antoniolli, Louisa Adolph, Michael Heide, Axel Lechner, Sarah Haebe, Elisa Osterode, Robert Kridel, Christoph Ziegenhain, Lucas Esteban Wange, Johannes Adrian Hildebrand, Tanaya Shree, Elisabeth Silkenstedt, Annette M. Staiger, German Ott, Heike Horn, Monika Szczepanowski, Julia Richter, Ronald Levy, Andreas Rosenwald, Wolfgang Enard, Ursula Zimber-Strobl, Michael von Bergwelt-Baildon, Wolfgang Hiddemann, Wolfram Klapper, Marc Schmidt-Supprian, Martina Rudelius, Deepak Bararia, Verena Passerini, Oliver Weigert
Publikováno v:
Leukemia 36, 2281–2292 (2022)
The variable clinical course of follicular lymphoma (FL) is determined by the molecular heterogeneity of tumor cells and complex interactions within the tumor microenvironment (TME). IL-4 producing follicular helper T cells (TFH) are critical compone
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b52b2cd1ee1154f74b7bbd0cba9836e2
https://doi.org/10.1038/s41375-022-01641-x
https://doi.org/10.1038/s41375-022-01641-x
Autor:
Stefano Testa, Ole A. W. Haabeth, Timothy R. Blake, Trevor J. Del Castillo, Debra K. Czerwinski, Ranjani Rajapaksa, Paul A. Wender, Robert M. Waymouth, Ronald Levy
Publikováno v:
Biomacromolecules
Charge-altering releasable transporters (CARTs) are a class of oligonucleotide delivery vehicles shown to be effective for delivery of messenger RNA (mRNA) both in vitro and in vivo. Here, we exploited the chemical versatility of the CART synthesis t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ca1a91d7d1e7a5448de07c5b4b68f26
https://doi.org/10.1021/acs.biomac.2c00469
https://doi.org/10.1021/acs.biomac.2c00469
Autor:
Caitlyn L. Miller, Idit Sagiv-Barfi, Patrick Neuhöfer, Debra K. Czerwinski, Carolyn R. Bertozzi, Jennifer R. Cochran, Ronald Levy
Publikováno v:
J Immunol
Spontaneous tumors that arise in genetically engineered mice recapitulate the natural tumor microenvironment and tumor-immune coevolution observed in human cancers, providing a more physiologically relevant preclinical model relative to implanted tum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::200b9571bd47703170c8ad7534707830
https://doi.org/10.4049/jimmunol.2200950
https://doi.org/10.4049/jimmunol.2200950
Autor:
Ronald Levy, Ash A. Alizadeh, Ranjana H. Advani, Lauren S. Maeda, Neel K. Gupta, Michael S. Khodadoust, David M. Kurtz, Etelka Gabriel, Karen S. Corbelli, Alyssa M. Kanegai, Sara Beygi, Gladys M. Rodriguez, Joseph G. Schroers-Martin, Debra K. Czerwinski, Julian J.K. Lohmeyer, Vishnu Shankar, Tanaya Shree
Supplementary Data from CD20-Targeted Therapy Ablates De Novo Antibody Response to Vaccination but Spares Preestablished Immunity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55e8a596f3480fe88d0d3f49612e3689
https://doi.org/10.1158/2643-3230.22544457.v1
https://doi.org/10.1158/2643-3230.22544457.v1
Autor:
Lee M. Greenberger, Ronald Levy, Steven D. Gore, Faith E. Davies, Katie M. Campbell, Madhav V. Dhodapkar, Antoni Ribas
Supplementary Table S1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e0bf586cf09e79974b73e4c0bd9e0f8
https://doi.org/10.1158/2643-3230.22543872
https://doi.org/10.1158/2643-3230.22543872
Autor:
Lee M. Greenberger, Ronald Levy, Steven D. Gore, Faith E. Davies, Katie M. Campbell, Madhav V. Dhodapkar, Antoni Ribas
Summary:Patients with hematologic malignancies are particularly vulnerable to COVID-19 infections, and upon a pooled data analysis of 24 publications, there is evidence that they have suboptimal antibody responses to COVID-19 vaccination and boosters
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2588d219d769956596509c89a4bb5aee
https://doi.org/10.1158/2643-3230.c.6550437.v1
https://doi.org/10.1158/2643-3230.c.6550437.v1